CBD Life Sciences (OTCMKTS:CBDL) Stock in Focus After The Recent Development

CBD Life Sciences (OTCMKTS:CBDL) on August 4, 2021 announced that its wholly owned subsidiary, LBC Bioscience expanding product line with fresh Vegan, non-GMO Gluten Free Gummies

New edible gummies will be in diverse flavours such as blue raspberry, candy apple, coconut, grape and lemonade+.

The gummies will be in a 4oz jar with 20mg of the finest hemp extract.

President & CEO Lisa Nelson said that the company is using highest quality ingredients for providing vegan and gluten-free recipe to clients. Nelson added that the company will continue to expand product lines especially the healthier route for people with diabetes, gluten allergies as well as vegans all around the world.

CBD edibles have no animal products besides being sweet and delicious. The CBD Gummies vegan can be useful both for mind as well as body for managing stress.

The vegan gummies can be carried in one’s pocket, making them an easy and healthy choice to consume on the go.

Using CBD gummies can facilitate improvement in immune system response, sleep as well as appetite. Children, having post-traumatic stress disorder, can also benefit from CBD to get good sleep and reduce stress.

CBD has number of advantages including neurological complications, anxiety, autism amongst others. CBD is also beneficial for pain management stemming from headaches, cramps, spinal injuries amongst others.

Related Posts

About The Author